Global Gene Therapy In Oncology Market Research Report 2025(Status and Outlook)
Gene therapy in oncology represents a cutting-edge therapeutic approach that involves the introduction, alteration, or regulation of genetic material within a patient?s cells to treat or prevent cancer, utilizing techniques such as viral vectors (e.g., lentiviruses or adeno-associated viruses) to deliver therapeutic genes?such as tumor suppressor genes, immune-stimulating genes, or gene-editing components like CRISPR-Cas9?directly into target cells, with the goal of correcting genetic mutations, enhancing the immune system?s ability to recognize and destroy cancer cells (as in CAR-T cell therapies), or inducing apoptosis in malignant cells, thereby offering a highly personalized and potentially curative treatment modality that differs fundamentally from traditional chemotherapy, radiation, or small-molecule inhibitors by targeting the underlying genetic drivers of cancer.
The global Gene Therapy In Oncology market size was estimated at USD 4434.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 22.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy In Oncology market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy In Oncology market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy In Oncology market.
Global Gene Therapy In Oncology Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen BiOthersapeutics
Tocagen
UniQure
Ziopharm Oncology
Market Segmentation (by Type)
Ex Vivo
In Vivo
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy In Oncology Market
Overview of the regional outlook of the Gene Therapy In Oncology Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy In Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy In Oncology, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gene Therapy In Oncology market size was estimated at USD 4434.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 22.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy In Oncology market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy In Oncology market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy In Oncology market.
Global Gene Therapy In Oncology Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen BiOthersapeutics
Tocagen
UniQure
Ziopharm Oncology
Market Segmentation (by Type)
Ex Vivo
In Vivo
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy In Oncology Market
Overview of the regional outlook of the Gene Therapy In Oncology Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy In Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy In Oncology, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy In Oncology
1.2 Key Market Segments
1.2.1 Gene Therapy In Oncology Segment by Type
1.2.2 Gene Therapy In Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY IN ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy In Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Therapy In Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY IN ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy In Oncology Product Life Cycle
3.3 Global Gene Therapy In Oncology Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy In Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy In Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy In Oncology Market Competitive Situation and Trends
3.8.1 Gene Therapy In Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy In Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy In Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY IN ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy In Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy In Oncology Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY IN ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy In Oncology Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy In Oncology Market Size Market Share by Type (2020-2025)
6.4 Global Gene Therapy In Oncology Price by Type (2020-2025)
7 GENE THERAPY IN ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy In Oncology Market Sales by Application (2020-2025)
7.3 Global Gene Therapy In Oncology Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY IN ONCOLOGY MARKET SALES BY REGION
8.1 Global Gene Therapy In Oncology Sales by Region
8.1.1 Global Gene Therapy In Oncology Sales by Region
8.1.2 Global Gene Therapy In Oncology Sales Market Share by Region
8.2 Global Gene Therapy In Oncology Market Size by Region
8.2.1 Global Gene Therapy In Oncology Market Size by Region
8.2.2 Global Gene Therapy In Oncology Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Therapy In Oncology Sales by Country
8.3.2 North America Gene Therapy In Oncology Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy In Oncology Sales by Country
8.4.2 Europe Gene Therapy In Oncology Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy In Oncology Sales by Region
8.5.2 Asia Pacific Gene Therapy In Oncology Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy In Oncology Sales by Country
8.6.2 South America Gene Therapy In Oncology Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy In Oncology Sales by Region
8.7.2 Middle East and Africa Gene Therapy In Oncology Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY IN ONCOLOGY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy In Oncology by Region(2020-2025)
9.2 Global Gene Therapy In Oncology Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy In Oncology Production
9.4.1 North America Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy In Oncology Production
9.5.1 Europe Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy In Oncology Production (2020-2025)
9.6.1 Japan Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy In Oncology Production (2020-2025)
9.7.1 China Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Basic Information
10.1.2 Bristol-Myers Squibb Gene Therapy In Oncology Product Overview
10.1.3 Bristol-Myers Squibb Gene Therapy In Oncology Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Cold Genesys
10.2.1 Cold Genesys Basic Information
10.2.2 Cold Genesys Gene Therapy In Oncology Product Overview
10.2.3 Cold Genesys Gene Therapy In Oncology Product Market Performance
10.2.4 Cold Genesys Business Overview
10.2.5 Cold Genesys SWOT Analysis
10.2.6 Cold Genesys Recent Developments
10.3 Advantagene
10.3.1 Advantagene Basic Information
10.3.2 Advantagene Gene Therapy In Oncology Product Overview
10.3.3 Advantagene Gene Therapy In Oncology Product Market Performance
10.3.4 Advantagene Business Overview
10.3.5 Advantagene SWOT Analysis
10.3.6 Advantagene Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Gene Therapy In Oncology Product Overview
10.4.3 Amgen Gene Therapy In Oncology Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Gene Therapy In Oncology Product Overview
10.5.3 AstraZeneca Gene Therapy In Oncology Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Bio-Path Holdings
10.6.1 Bio-Path Holdings Basic Information
10.6.2 Bio-Path Holdings Gene Therapy In Oncology Product Overview
10.6.3 Bio-Path Holdings Gene Therapy In Oncology Product Market Performance
10.6.4 Bio-Path Holdings Business Overview
10.6.5 Bio-Path Holdings Recent Developments
10.7 CRISPR Therapeutics
10.7.1 CRISPR Therapeutics Basic Information
10.7.2 CRISPR Therapeutics Gene Therapy In Oncology Product Overview
10.7.3 CRISPR Therapeutics Gene Therapy In Oncology Product Market Performance
10.7.4 CRISPR Therapeutics Business Overview
10.7.5 CRISPR Therapeutics Recent Developments
10.8 Editas Medicine
10.8.1 Editas Medicine Basic Information
10.8.2 Editas Medicine Gene Therapy In Oncology Product Overview
10.8.3 Editas Medicine Gene Therapy In Oncology Product Market Performance
10.8.4 Editas Medicine Business Overview
10.8.5 Editas Medicine Recent Developments
10.9 Geron Corp
10.9.1 Geron Corp Basic Information
10.9.2 Geron Corp Gene Therapy In Oncology Product Overview
10.9.3 Geron Corp Gene Therapy In Oncology Product Market Performance
10.9.4 Geron Corp Business Overview
10.9.5 Geron Corp Recent Developments
10.10 Idera Pharmaceuticals
10.10.1 Idera Pharmaceuticals Basic Information
10.10.2 Idera Pharmaceuticals Gene Therapy In Oncology Product Overview
10.10.3 Idera Pharmaceuticals Gene Therapy In Oncology Product Market Performance
10.10.4 Idera Pharmaceuticals Business Overview
10.10.5 Idera Pharmaceuticals Recent Developments
10.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Basic Information
10.11.2 Intellia Therapeutics Gene Therapy In Oncology Product Overview
10.11.3 Intellia Therapeutics Gene Therapy In Oncology Product Market Performance
10.11.4 Intellia Therapeutics Business Overview
10.11.5 Intellia Therapeutics Recent Developments
10.12 Johnson and Johnson
10.12.1 Johnson and Johnson Basic Information
10.12.2 Johnson and Johnson Gene Therapy In Oncology Product Overview
10.12.3 Johnson and Johnson Gene Therapy In Oncology Product Market Performance
10.12.4 Johnson and Johnson Business Overview
10.12.5 Johnson and Johnson Recent Developments
10.13 Marsala Biotech
10.13.1 Marsala Biotech Basic Information
10.13.2 Marsala Biotech Gene Therapy In Oncology Product Overview
10.13.3 Marsala Biotech Gene Therapy In Oncology Product Market Performance
10.13.4 Marsala Biotech Business Overview
10.13.5 Marsala Biotech Recent Developments
10.14 Merck
10.14.1 Merck Basic Information
10.14.2 Merck Gene Therapy In Oncology Product Overview
10.14.3 Merck Gene Therapy In Oncology Product Market Performance
10.14.4 Merck Business Overview
10.14.5 Merck Recent Developments
10.15 Mologen AG
10.15.1 Mologen AG Basic Information
10.15.2 Mologen AG Gene Therapy In Oncology Product Overview
10.15.3 Mologen AG Gene Therapy In Oncology Product Market Performance
10.15.4 Mologen AG Business Overview
10.15.5 Mologen AG Recent Developments
10.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Basic Information
10.16.2 Oncolytics Biotech Gene Therapy In Oncology Product Overview
10.16.3 Oncolytics Biotech Gene Therapy In Oncology Product Market Performance
10.16.4 Oncolytics Biotech Business Overview
10.16.5 Oncolytics Biotech Recent Developments
10.17 Oncosec
10.17.1 Oncosec Basic Information
10.17.2 Oncosec Gene Therapy In Oncology Product Overview
10.17.3 Oncosec Gene Therapy In Oncology Product Market Performance
10.17.4 Oncosec Business Overview
10.17.5 Oncosec Recent Developments
10.18 Oncotelic
10.18.1 Oncotelic Basic Information
10.18.2 Oncotelic Gene Therapy In Oncology Product Overview
10.18.3 Oncotelic Gene Therapy In Oncology Product Market Performance
10.18.4 Oncotelic Business Overview
10.18.5 Oncotelic Recent Developments
10.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Basic Information
10.19.2 Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Overview
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Market Performance
10.19.4 Shenzhen SiBiono GeneTech Business Overview
10.19.5 Shenzhen SiBiono GeneTech Recent Developments
10.20 Sillajen BiOthersapeutics
10.20.1 Sillajen BiOthersapeutics Basic Information
10.20.2 Sillajen BiOthersapeutics Gene Therapy In Oncology Product Overview
10.20.3 Sillajen BiOthersapeutics Gene Therapy In Oncology Product Market Performance
10.20.4 Sillajen BiOthersapeutics Business Overview
10.20.5 Sillajen BiOthersapeutics Recent Developments
10.21 Tocagen
10.21.1 Tocagen Basic Information
10.21.2 Tocagen Gene Therapy In Oncology Product Overview
10.21.3 Tocagen Gene Therapy In Oncology Product Market Performance
10.21.4 Tocagen Business Overview
10.21.5 Tocagen Recent Developments
10.22 UniQure
10.22.1 UniQure Basic Information
10.22.2 UniQure Gene Therapy In Oncology Product Overview
10.22.3 UniQure Gene Therapy In Oncology Product Market Performance
10.22.4 UniQure Business Overview
10.22.5 UniQure Recent Developments
10.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Basic Information
10.23.2 Ziopharm Oncology Gene Therapy In Oncology Product Overview
10.23.3 Ziopharm Oncology Gene Therapy In Oncology Product Market Performance
10.23.4 Ziopharm Oncology Business Overview
10.23.5 Ziopharm Oncology Recent Developments
11 GENE THERAPY IN ONCOLOGY MARKET FORECAST BY REGION
11.1 Global Gene Therapy In Oncology Market Size Forecast
11.2 Global Gene Therapy In Oncology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy In Oncology Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy In Oncology Market Size Forecast by Region
11.2.4 South America Gene Therapy In Oncology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy In Oncology by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Therapy In Oncology Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Therapy In Oncology by Type (2026-2033)
12.1.2 Global Gene Therapy In Oncology Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Therapy In Oncology by Type (2026-2033)
12.2 Global Gene Therapy In Oncology Market Forecast by Application (2026-2033)
12.2.1 Global Gene Therapy In Oncology Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy In Oncology Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy In Oncology
1.2 Key Market Segments
1.2.1 Gene Therapy In Oncology Segment by Type
1.2.2 Gene Therapy In Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY IN ONCOLOGY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy In Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Therapy In Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY IN ONCOLOGY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy In Oncology Product Life Cycle
3.3 Global Gene Therapy In Oncology Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy In Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy In Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy In Oncology Market Competitive Situation and Trends
3.8.1 Gene Therapy In Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy In Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy In Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY IN ONCOLOGY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy In Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy In Oncology Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY IN ONCOLOGY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy In Oncology Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy In Oncology Market Size Market Share by Type (2020-2025)
6.4 Global Gene Therapy In Oncology Price by Type (2020-2025)
7 GENE THERAPY IN ONCOLOGY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy In Oncology Market Sales by Application (2020-2025)
7.3 Global Gene Therapy In Oncology Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY IN ONCOLOGY MARKET SALES BY REGION
8.1 Global Gene Therapy In Oncology Sales by Region
8.1.1 Global Gene Therapy In Oncology Sales by Region
8.1.2 Global Gene Therapy In Oncology Sales Market Share by Region
8.2 Global Gene Therapy In Oncology Market Size by Region
8.2.1 Global Gene Therapy In Oncology Market Size by Region
8.2.2 Global Gene Therapy In Oncology Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Therapy In Oncology Sales by Country
8.3.2 North America Gene Therapy In Oncology Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy In Oncology Sales by Country
8.4.2 Europe Gene Therapy In Oncology Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy In Oncology Sales by Region
8.5.2 Asia Pacific Gene Therapy In Oncology Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy In Oncology Sales by Country
8.6.2 South America Gene Therapy In Oncology Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy In Oncology Sales by Region
8.7.2 Middle East and Africa Gene Therapy In Oncology Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY IN ONCOLOGY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy In Oncology by Region(2020-2025)
9.2 Global Gene Therapy In Oncology Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy In Oncology Production
9.4.1 North America Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy In Oncology Production
9.5.1 Europe Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy In Oncology Production (2020-2025)
9.6.1 Japan Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy In Oncology Production (2020-2025)
9.7.1 China Gene Therapy In Oncology Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy In Oncology Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Basic Information
10.1.2 Bristol-Myers Squibb Gene Therapy In Oncology Product Overview
10.1.3 Bristol-Myers Squibb Gene Therapy In Oncology Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Cold Genesys
10.2.1 Cold Genesys Basic Information
10.2.2 Cold Genesys Gene Therapy In Oncology Product Overview
10.2.3 Cold Genesys Gene Therapy In Oncology Product Market Performance
10.2.4 Cold Genesys Business Overview
10.2.5 Cold Genesys SWOT Analysis
10.2.6 Cold Genesys Recent Developments
10.3 Advantagene
10.3.1 Advantagene Basic Information
10.3.2 Advantagene Gene Therapy In Oncology Product Overview
10.3.3 Advantagene Gene Therapy In Oncology Product Market Performance
10.3.4 Advantagene Business Overview
10.3.5 Advantagene SWOT Analysis
10.3.6 Advantagene Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Gene Therapy In Oncology Product Overview
10.4.3 Amgen Gene Therapy In Oncology Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Gene Therapy In Oncology Product Overview
10.5.3 AstraZeneca Gene Therapy In Oncology Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Bio-Path Holdings
10.6.1 Bio-Path Holdings Basic Information
10.6.2 Bio-Path Holdings Gene Therapy In Oncology Product Overview
10.6.3 Bio-Path Holdings Gene Therapy In Oncology Product Market Performance
10.6.4 Bio-Path Holdings Business Overview
10.6.5 Bio-Path Holdings Recent Developments
10.7 CRISPR Therapeutics
10.7.1 CRISPR Therapeutics Basic Information
10.7.2 CRISPR Therapeutics Gene Therapy In Oncology Product Overview
10.7.3 CRISPR Therapeutics Gene Therapy In Oncology Product Market Performance
10.7.4 CRISPR Therapeutics Business Overview
10.7.5 CRISPR Therapeutics Recent Developments
10.8 Editas Medicine
10.8.1 Editas Medicine Basic Information
10.8.2 Editas Medicine Gene Therapy In Oncology Product Overview
10.8.3 Editas Medicine Gene Therapy In Oncology Product Market Performance
10.8.4 Editas Medicine Business Overview
10.8.5 Editas Medicine Recent Developments
10.9 Geron Corp
10.9.1 Geron Corp Basic Information
10.9.2 Geron Corp Gene Therapy In Oncology Product Overview
10.9.3 Geron Corp Gene Therapy In Oncology Product Market Performance
10.9.4 Geron Corp Business Overview
10.9.5 Geron Corp Recent Developments
10.10 Idera Pharmaceuticals
10.10.1 Idera Pharmaceuticals Basic Information
10.10.2 Idera Pharmaceuticals Gene Therapy In Oncology Product Overview
10.10.3 Idera Pharmaceuticals Gene Therapy In Oncology Product Market Performance
10.10.4 Idera Pharmaceuticals Business Overview
10.10.5 Idera Pharmaceuticals Recent Developments
10.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Basic Information
10.11.2 Intellia Therapeutics Gene Therapy In Oncology Product Overview
10.11.3 Intellia Therapeutics Gene Therapy In Oncology Product Market Performance
10.11.4 Intellia Therapeutics Business Overview
10.11.5 Intellia Therapeutics Recent Developments
10.12 Johnson and Johnson
10.12.1 Johnson and Johnson Basic Information
10.12.2 Johnson and Johnson Gene Therapy In Oncology Product Overview
10.12.3 Johnson and Johnson Gene Therapy In Oncology Product Market Performance
10.12.4 Johnson and Johnson Business Overview
10.12.5 Johnson and Johnson Recent Developments
10.13 Marsala Biotech
10.13.1 Marsala Biotech Basic Information
10.13.2 Marsala Biotech Gene Therapy In Oncology Product Overview
10.13.3 Marsala Biotech Gene Therapy In Oncology Product Market Performance
10.13.4 Marsala Biotech Business Overview
10.13.5 Marsala Biotech Recent Developments
10.14 Merck
10.14.1 Merck Basic Information
10.14.2 Merck Gene Therapy In Oncology Product Overview
10.14.3 Merck Gene Therapy In Oncology Product Market Performance
10.14.4 Merck Business Overview
10.14.5 Merck Recent Developments
10.15 Mologen AG
10.15.1 Mologen AG Basic Information
10.15.2 Mologen AG Gene Therapy In Oncology Product Overview
10.15.3 Mologen AG Gene Therapy In Oncology Product Market Performance
10.15.4 Mologen AG Business Overview
10.15.5 Mologen AG Recent Developments
10.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Basic Information
10.16.2 Oncolytics Biotech Gene Therapy In Oncology Product Overview
10.16.3 Oncolytics Biotech Gene Therapy In Oncology Product Market Performance
10.16.4 Oncolytics Biotech Business Overview
10.16.5 Oncolytics Biotech Recent Developments
10.17 Oncosec
10.17.1 Oncosec Basic Information
10.17.2 Oncosec Gene Therapy In Oncology Product Overview
10.17.3 Oncosec Gene Therapy In Oncology Product Market Performance
10.17.4 Oncosec Business Overview
10.17.5 Oncosec Recent Developments
10.18 Oncotelic
10.18.1 Oncotelic Basic Information
10.18.2 Oncotelic Gene Therapy In Oncology Product Overview
10.18.3 Oncotelic Gene Therapy In Oncology Product Market Performance
10.18.4 Oncotelic Business Overview
10.18.5 Oncotelic Recent Developments
10.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Basic Information
10.19.2 Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Overview
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Market Performance
10.19.4 Shenzhen SiBiono GeneTech Business Overview
10.19.5 Shenzhen SiBiono GeneTech Recent Developments
10.20 Sillajen BiOthersapeutics
10.20.1 Sillajen BiOthersapeutics Basic Information
10.20.2 Sillajen BiOthersapeutics Gene Therapy In Oncology Product Overview
10.20.3 Sillajen BiOthersapeutics Gene Therapy In Oncology Product Market Performance
10.20.4 Sillajen BiOthersapeutics Business Overview
10.20.5 Sillajen BiOthersapeutics Recent Developments
10.21 Tocagen
10.21.1 Tocagen Basic Information
10.21.2 Tocagen Gene Therapy In Oncology Product Overview
10.21.3 Tocagen Gene Therapy In Oncology Product Market Performance
10.21.4 Tocagen Business Overview
10.21.5 Tocagen Recent Developments
10.22 UniQure
10.22.1 UniQure Basic Information
10.22.2 UniQure Gene Therapy In Oncology Product Overview
10.22.3 UniQure Gene Therapy In Oncology Product Market Performance
10.22.4 UniQure Business Overview
10.22.5 UniQure Recent Developments
10.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Basic Information
10.23.2 Ziopharm Oncology Gene Therapy In Oncology Product Overview
10.23.3 Ziopharm Oncology Gene Therapy In Oncology Product Market Performance
10.23.4 Ziopharm Oncology Business Overview
10.23.5 Ziopharm Oncology Recent Developments
11 GENE THERAPY IN ONCOLOGY MARKET FORECAST BY REGION
11.1 Global Gene Therapy In Oncology Market Size Forecast
11.2 Global Gene Therapy In Oncology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy In Oncology Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy In Oncology Market Size Forecast by Region
11.2.4 South America Gene Therapy In Oncology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy In Oncology by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Therapy In Oncology Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Therapy In Oncology by Type (2026-2033)
12.1.2 Global Gene Therapy In Oncology Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Therapy In Oncology by Type (2026-2033)
12.2 Global Gene Therapy In Oncology Market Forecast by Application (2026-2033)
12.2.1 Global Gene Therapy In Oncology Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy In Oncology Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy In Oncology Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy In Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Therapy In Oncology Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Therapy In Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Therapy In Oncology Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy In Oncology as of 2024)
Table 10. Global Market Gene Therapy In Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Therapy In Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Therapy In Oncology Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Therapy In Oncology Sales by Type (K Units)
Table 26. Global Gene Therapy In Oncology Market Size by Type (M USD)
Table 27. Global Gene Therapy In Oncology Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Therapy In Oncology Sales Market Share by Type (2020-2025)
Table 29. Global Gene Therapy In Oncology Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Therapy In Oncology Market Size Share by Type (2020-2025)
Table 31. Global Gene Therapy In Oncology Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Therapy In Oncology Sales (K Units) by Application
Table 33. Global Gene Therapy In Oncology Market Size by Application
Table 34. Global Gene Therapy In Oncology Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Therapy In Oncology Sales Market Share by Application (2020-2025)
Table 36. Global Gene Therapy In Oncology Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Therapy In Oncology Market Share by Application (2020-2025)
Table 38. Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Therapy In Oncology Sales Market Share by Region (2020-2025)
Table 41. Global Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Therapy In Oncology Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Therapy In Oncology Production (K Units) by Region(2020-2025)
Table 54. Global Gene Therapy In Oncology Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Therapy In Oncology Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Bristol-Myers Squibb Basic Information
Table 62. Bristol-Myers Squibb Gene Therapy In Oncology Product Overview
Table 63. Bristol-Myers Squibb Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb SWOT Analysis
Table 66. Bristol-Myers Squibb Recent Developments
Table 67. Cold Genesys Basic Information
Table 68. Cold Genesys Gene Therapy In Oncology Product Overview
Table 69. Cold Genesys Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Cold Genesys Business Overview
Table 71. Cold Genesys SWOT Analysis
Table 72. Cold Genesys Recent Developments
Table 73. Advantagene Basic Information
Table 74. Advantagene Gene Therapy In Oncology Product Overview
Table 75. Advantagene Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Advantagene Business Overview
Table 77. Advantagene SWOT Analysis
Table 78. Advantagene Recent Developments
Table 79. Amgen Basic Information
Table 80. Amgen Gene Therapy In Oncology Product Overview
Table 81. Amgen Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Amgen Business Overview
Table 83. Amgen Recent Developments
Table 84. AstraZeneca Basic Information
Table 85. AstraZeneca Gene Therapy In Oncology Product Overview
Table 86. AstraZeneca Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Recent Developments
Table 89. Bio-Path Holdings Basic Information
Table 90. Bio-Path Holdings Gene Therapy In Oncology Product Overview
Table 91. Bio-Path Holdings Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bio-Path Holdings Business Overview
Table 93. Bio-Path Holdings Recent Developments
Table 94. CRISPR Therapeutics Basic Information
Table 95. CRISPR Therapeutics Gene Therapy In Oncology Product Overview
Table 96. CRISPR Therapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. CRISPR Therapeutics Business Overview
Table 98. CRISPR Therapeutics Recent Developments
Table 99. Editas Medicine Basic Information
Table 100. Editas Medicine Gene Therapy In Oncology Product Overview
Table 101. Editas Medicine Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Editas Medicine Business Overview
Table 103. Editas Medicine Recent Developments
Table 104. Geron Corp Basic Information
Table 105. Geron Corp Gene Therapy In Oncology Product Overview
Table 106. Geron Corp Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Geron Corp Business Overview
Table 108. Geron Corp Recent Developments
Table 109. Idera Pharmaceuticals Basic Information
Table 110. Idera Pharmaceuticals Gene Therapy In Oncology Product Overview
Table 111. Idera Pharmaceuticals Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Idera Pharmaceuticals Business Overview
Table 113. Idera Pharmaceuticals Recent Developments
Table 114. Intellia Therapeutics Basic Information
Table 115. Intellia Therapeutics Gene Therapy In Oncology Product Overview
Table 116. Intellia Therapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Intellia Therapeutics Business Overview
Table 118. Intellia Therapeutics Recent Developments
Table 119. Johnson and Johnson Basic Information
Table 120. Johnson and Johnson Gene Therapy In Oncology Product Overview
Table 121. Johnson and Johnson Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Johnson and Johnson Business Overview
Table 123. Johnson and Johnson Recent Developments
Table 124. Marsala Biotech Basic Information
Table 125. Marsala Biotech Gene Therapy In Oncology Product Overview
Table 126. Marsala Biotech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Marsala Biotech Business Overview
Table 128. Marsala Biotech Recent Developments
Table 129. Merck Basic Information
Table 130. Merck Gene Therapy In Oncology Product Overview
Table 131. Merck Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Merck Business Overview
Table 133. Merck Recent Developments
Table 134. Mologen AG Basic Information
Table 135. Mologen AG Gene Therapy In Oncology Product Overview
Table 136. Mologen AG Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Mologen AG Business Overview
Table 138. Mologen AG Recent Developments
Table 139. Oncolytics Biotech Basic Information
Table 140. Oncolytics Biotech Gene Therapy In Oncology Product Overview
Table 141. Oncolytics Biotech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Oncolytics Biotech Business Overview
Table 143. Oncolytics Biotech Recent Developments
Table 144. Oncosec Basic Information
Table 145. Oncosec Gene Therapy In Oncology Product Overview
Table 146. Oncosec Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Oncosec Business Overview
Table 148. Oncosec Recent Developments
Table 149. Oncotelic Basic Information
Table 150. Oncotelic Gene Therapy In Oncology Product Overview
Table 151. Oncotelic Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Oncotelic Business Overview
Table 153. Oncotelic Recent Developments
Table 154. Shenzhen SiBiono GeneTech Basic Information
Table 155. Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Overview
Table 156. Shenzhen SiBiono GeneTech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Shenzhen SiBiono GeneTech Business Overview
Table 158. Shenzhen SiBiono GeneTech Recent Developments
Table 159. Sillajen BiOthersapeutics Basic Information
Table 160. Sillajen BiOthersapeutics Gene Therapy In Oncology Product Overview
Table 161. Sillajen BiOthersapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Sillajen BiOthersapeutics Business Overview
Table 163. Sillajen BiOthersapeutics Recent Developments
Table 164. Tocagen Basic Information
Table 165. Tocagen Gene Therapy In Oncology Product Overview
Table 166. Tocagen Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Tocagen Business Overview
Table 168. Tocagen Recent Developments
Table 169. UniQure Basic Information
Table 170. UniQure Gene Therapy In Oncology Product Overview
Table 171. UniQure Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. UniQure Business Overview
Table 173. UniQure Recent Developments
Table 174. Ziopharm Oncology Basic Information
Table 175. Ziopharm Oncology Gene Therapy In Oncology Product Overview
Table 176. Ziopharm Oncology Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Ziopharm Oncology Business Overview
Table 178. Ziopharm Oncology Recent Developments
Table 179. Global Gene Therapy In Oncology Sales Forecast by Region (2026-2033) & (K Units)
Table 180. Global Gene Therapy In Oncology Market Size Forecast by Region (2026-2033) & (M USD)
Table 181. North America Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 182. North America Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 183. Europe Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 184. Europe Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 185. Asia Pacific Gene Therapy In Oncology Sales Forecast by Region (2026-2033) & (K Units)
Table 186. Asia Pacific Gene Therapy In Oncology Market Size Forecast by Region (2026-2033) & (M USD)
Table 187. South America Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 188. South America Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 189. Middle East and Africa Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (Units)
Table 190. Middle East and Africa Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Global Gene Therapy In Oncology Sales Forecast by Type (2026-2033) & (K Units)
Table 192. Global Gene Therapy In Oncology Market Size Forecast by Type (2026-2033) & (M USD)
Table 193. Global Gene Therapy In Oncology Price Forecast by Type (2026-2033) & (USD/Unit)
Table 194. Global Gene Therapy In Oncology Sales (K Units) Forecast by Application (2026-2033)
Table 195. Global Gene Therapy In Oncology Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy In Oncology Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy In Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Therapy In Oncology Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Therapy In Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Therapy In Oncology Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy In Oncology as of 2024)
Table 10. Global Market Gene Therapy In Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Therapy In Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Therapy In Oncology Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Therapy In Oncology Sales by Type (K Units)
Table 26. Global Gene Therapy In Oncology Market Size by Type (M USD)
Table 27. Global Gene Therapy In Oncology Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Therapy In Oncology Sales Market Share by Type (2020-2025)
Table 29. Global Gene Therapy In Oncology Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Therapy In Oncology Market Size Share by Type (2020-2025)
Table 31. Global Gene Therapy In Oncology Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Therapy In Oncology Sales (K Units) by Application
Table 33. Global Gene Therapy In Oncology Market Size by Application
Table 34. Global Gene Therapy In Oncology Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Therapy In Oncology Sales Market Share by Application (2020-2025)
Table 36. Global Gene Therapy In Oncology Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Therapy In Oncology Market Share by Application (2020-2025)
Table 38. Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Therapy In Oncology Sales Market Share by Region (2020-2025)
Table 41. Global Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Therapy In Oncology Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Therapy In Oncology Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Therapy In Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Therapy In Oncology Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Therapy In Oncology Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Therapy In Oncology Production (K Units) by Region(2020-2025)
Table 54. Global Gene Therapy In Oncology Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Therapy In Oncology Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Therapy In Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Bristol-Myers Squibb Basic Information
Table 62. Bristol-Myers Squibb Gene Therapy In Oncology Product Overview
Table 63. Bristol-Myers Squibb Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb SWOT Analysis
Table 66. Bristol-Myers Squibb Recent Developments
Table 67. Cold Genesys Basic Information
Table 68. Cold Genesys Gene Therapy In Oncology Product Overview
Table 69. Cold Genesys Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Cold Genesys Business Overview
Table 71. Cold Genesys SWOT Analysis
Table 72. Cold Genesys Recent Developments
Table 73. Advantagene Basic Information
Table 74. Advantagene Gene Therapy In Oncology Product Overview
Table 75. Advantagene Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Advantagene Business Overview
Table 77. Advantagene SWOT Analysis
Table 78. Advantagene Recent Developments
Table 79. Amgen Basic Information
Table 80. Amgen Gene Therapy In Oncology Product Overview
Table 81. Amgen Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Amgen Business Overview
Table 83. Amgen Recent Developments
Table 84. AstraZeneca Basic Information
Table 85. AstraZeneca Gene Therapy In Oncology Product Overview
Table 86. AstraZeneca Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Recent Developments
Table 89. Bio-Path Holdings Basic Information
Table 90. Bio-Path Holdings Gene Therapy In Oncology Product Overview
Table 91. Bio-Path Holdings Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Bio-Path Holdings Business Overview
Table 93. Bio-Path Holdings Recent Developments
Table 94. CRISPR Therapeutics Basic Information
Table 95. CRISPR Therapeutics Gene Therapy In Oncology Product Overview
Table 96. CRISPR Therapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. CRISPR Therapeutics Business Overview
Table 98. CRISPR Therapeutics Recent Developments
Table 99. Editas Medicine Basic Information
Table 100. Editas Medicine Gene Therapy In Oncology Product Overview
Table 101. Editas Medicine Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Editas Medicine Business Overview
Table 103. Editas Medicine Recent Developments
Table 104. Geron Corp Basic Information
Table 105. Geron Corp Gene Therapy In Oncology Product Overview
Table 106. Geron Corp Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Geron Corp Business Overview
Table 108. Geron Corp Recent Developments
Table 109. Idera Pharmaceuticals Basic Information
Table 110. Idera Pharmaceuticals Gene Therapy In Oncology Product Overview
Table 111. Idera Pharmaceuticals Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Idera Pharmaceuticals Business Overview
Table 113. Idera Pharmaceuticals Recent Developments
Table 114. Intellia Therapeutics Basic Information
Table 115. Intellia Therapeutics Gene Therapy In Oncology Product Overview
Table 116. Intellia Therapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Intellia Therapeutics Business Overview
Table 118. Intellia Therapeutics Recent Developments
Table 119. Johnson and Johnson Basic Information
Table 120. Johnson and Johnson Gene Therapy In Oncology Product Overview
Table 121. Johnson and Johnson Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Johnson and Johnson Business Overview
Table 123. Johnson and Johnson Recent Developments
Table 124. Marsala Biotech Basic Information
Table 125. Marsala Biotech Gene Therapy In Oncology Product Overview
Table 126. Marsala Biotech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Marsala Biotech Business Overview
Table 128. Marsala Biotech Recent Developments
Table 129. Merck Basic Information
Table 130. Merck Gene Therapy In Oncology Product Overview
Table 131. Merck Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Merck Business Overview
Table 133. Merck Recent Developments
Table 134. Mologen AG Basic Information
Table 135. Mologen AG Gene Therapy In Oncology Product Overview
Table 136. Mologen AG Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Mologen AG Business Overview
Table 138. Mologen AG Recent Developments
Table 139. Oncolytics Biotech Basic Information
Table 140. Oncolytics Biotech Gene Therapy In Oncology Product Overview
Table 141. Oncolytics Biotech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Oncolytics Biotech Business Overview
Table 143. Oncolytics Biotech Recent Developments
Table 144. Oncosec Basic Information
Table 145. Oncosec Gene Therapy In Oncology Product Overview
Table 146. Oncosec Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Oncosec Business Overview
Table 148. Oncosec Recent Developments
Table 149. Oncotelic Basic Information
Table 150. Oncotelic Gene Therapy In Oncology Product Overview
Table 151. Oncotelic Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Oncotelic Business Overview
Table 153. Oncotelic Recent Developments
Table 154. Shenzhen SiBiono GeneTech Basic Information
Table 155. Shenzhen SiBiono GeneTech Gene Therapy In Oncology Product Overview
Table 156. Shenzhen SiBiono GeneTech Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Shenzhen SiBiono GeneTech Business Overview
Table 158. Shenzhen SiBiono GeneTech Recent Developments
Table 159. Sillajen BiOthersapeutics Basic Information
Table 160. Sillajen BiOthersapeutics Gene Therapy In Oncology Product Overview
Table 161. Sillajen BiOthersapeutics Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Sillajen BiOthersapeutics Business Overview
Table 163. Sillajen BiOthersapeutics Recent Developments
Table 164. Tocagen Basic Information
Table 165. Tocagen Gene Therapy In Oncology Product Overview
Table 166. Tocagen Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Tocagen Business Overview
Table 168. Tocagen Recent Developments
Table 169. UniQure Basic Information
Table 170. UniQure Gene Therapy In Oncology Product Overview
Table 171. UniQure Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. UniQure Business Overview
Table 173. UniQure Recent Developments
Table 174. Ziopharm Oncology Basic Information
Table 175. Ziopharm Oncology Gene Therapy In Oncology Product Overview
Table 176. Ziopharm Oncology Gene Therapy In Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Ziopharm Oncology Business Overview
Table 178. Ziopharm Oncology Recent Developments
Table 179. Global Gene Therapy In Oncology Sales Forecast by Region (2026-2033) & (K Units)
Table 180. Global Gene Therapy In Oncology Market Size Forecast by Region (2026-2033) & (M USD)
Table 181. North America Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 182. North America Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 183. Europe Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 184. Europe Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 185. Asia Pacific Gene Therapy In Oncology Sales Forecast by Region (2026-2033) & (K Units)
Table 186. Asia Pacific Gene Therapy In Oncology Market Size Forecast by Region (2026-2033) & (M USD)
Table 187. South America Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (K Units)
Table 188. South America Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 189. Middle East and Africa Gene Therapy In Oncology Sales Forecast by Country (2026-2033) & (Units)
Table 190. Middle East and Africa Gene Therapy In Oncology Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Global Gene Therapy In Oncology Sales Forecast by Type (2026-2033) & (K Units)
Table 192. Global Gene Therapy In Oncology Market Size Forecast by Type (2026-2033) & (M USD)
Table 193. Global Gene Therapy In Oncology Price Forecast by Type (2026-2033) & (USD/Unit)
Table 194. Global Gene Therapy In Oncology Sales (K Units) Forecast by Application (2026-2033)
Table 195. Global Gene Therapy In Oncology Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy In Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy In Oncology Market Size (M USD), 2024-2033
Figure 5. Global Gene Therapy In Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Gene Therapy In Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy In Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy In Oncology Product Life Cycle
Figure 13. Gene Therapy In Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Gene Therapy In Oncology Revenue Share by Manufacturers in 2024
Figure 15. Gene Therapy In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Therapy In Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy In Oncology Revenue in 2024
Figure 18. Industry Chain Map of Gene Therapy In Oncology
Figure 19. Global Gene Therapy In Oncology Market PEST Analysis
Figure 20. Global Gene Therapy In Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy In Oncology Market Share by Type
Figure 27. Sales Market Share of Gene Therapy In Oncology by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy In Oncology by Type in 2024
Figure 29. Market Size Share of Gene Therapy In Oncology by Type (2020-2025)
Figure 30. Market Size Share of Gene Therapy In Oncology by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy In Oncology Market Share by Application
Figure 33. Global Gene Therapy In Oncology Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy In Oncology Sales Market Share by Application in 2024
Figure 35. Global Gene Therapy In Oncology Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy In Oncology Market Share by Application in 2024
Figure 37. Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy In Oncology Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy In Oncology Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy In Oncology Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy In Oncology Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy In Oncology Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy In Oncology Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 55. Germany Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy In Oncology Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy In Oncology Market Size Market Share by Region in 2024
Figure 68. China Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy In Oncology Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy In Oncology Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy In Oncology Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy In Oncology Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy In Oncology Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy In Oncology Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Therapy In Oncology Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Therapy In Oncology Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Therapy In Oncology Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Therapy In Oncology Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Therapy In Oncology Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Gene Therapy In Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy In Oncology Market Size (M USD), 2024-2033
Figure 5. Global Gene Therapy In Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Gene Therapy In Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy In Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy In Oncology Product Life Cycle
Figure 13. Gene Therapy In Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Gene Therapy In Oncology Revenue Share by Manufacturers in 2024
Figure 15. Gene Therapy In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Therapy In Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy In Oncology Revenue in 2024
Figure 18. Industry Chain Map of Gene Therapy In Oncology
Figure 19. Global Gene Therapy In Oncology Market PEST Analysis
Figure 20. Global Gene Therapy In Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy In Oncology Market Share by Type
Figure 27. Sales Market Share of Gene Therapy In Oncology by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy In Oncology by Type in 2024
Figure 29. Market Size Share of Gene Therapy In Oncology by Type (2020-2025)
Figure 30. Market Size Share of Gene Therapy In Oncology by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy In Oncology Market Share by Application
Figure 33. Global Gene Therapy In Oncology Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy In Oncology Sales Market Share by Application in 2024
Figure 35. Global Gene Therapy In Oncology Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy In Oncology Market Share by Application in 2024
Figure 37. Global Gene Therapy In Oncology Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy In Oncology Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy In Oncology Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy In Oncology Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy In Oncology Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy In Oncology Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy In Oncology Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 55. Germany Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy In Oncology Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy In Oncology Market Size Market Share by Region in 2024
Figure 68. China Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy In Oncology Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy In Oncology Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy In Oncology Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy In Oncology Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy In Oncology Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy In Oncology Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy In Oncology Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy In Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy In Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy In Oncology Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy In Oncology Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy In Oncology Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Therapy In Oncology Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Therapy In Oncology Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Therapy In Oncology Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Therapy In Oncology Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Therapy In Oncology Market Share Forecast by Application (2026-2033)
